| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $31.04 (Miss by $-1.67) |
| EPS GAAP Actual | $31.04 (Miss by $-1.67) |
| Revenue Actual | $4.62863B |
| Revenue Surprise | Beat by $4628.63M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Aug 2030 | 246.51 | 13.76 | 238.11981 | 252.76259 | 4 |
| Aug 2030 | 246.51 | 13.76 | 238.31425 | 253.61323 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 31.88 | 31.88 | 4.62863B | 7.54% | 4628.63M |
| FQ3 2025 (Aug 2025) | 50.02 | 50.02 | 6.24273B | 0.6% | 6242.73M |
| FQ2 2025 (May 2025) | 36.33 | 36.33 | 4.46434B | 5.13% | 4464.34M |
| FQ1 2025 (Feb 2025) | 28.29 | 28.29 | 3.95201B | 100% | 3952.01M |
| FQ4 2024 (Nov 2024) | 33.4 | 33.4 | 4.27964B | 100% | 4279.64M |
| FQ3 2024 (Aug 2024) | 53.28 | 53.28 | 6.20538B | 100% | 6205.38M |
| FQ2 2024 (Apr 2024) | 37.73 | 37.73 | 4.23548B | 100% | 4235.48M |
| FQ2 2022 (May 2022) | 29.93 | 29.93 | 3.86522B | 100% | 3865.22M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 71.5236 | -- | 70.076 | 73.34573 | 20 |
| FQ2 2028 (May 2028) | 70.1653 | -- | 68.74519 | 71.95283 | 19 |
| FQ1 2028 (Feb 2028) | 50.1718 | -- | 49.15635 | 51.44997 | 18 |
| FQ4 2027 (Nov 2027) | 39.7152 | -- | 38.91138 | 40.72698 | 10 |
| FQ3 2027 (Aug 2027) | 64.99 | -- | 64.99 | 64.99 | 12 |
| FQ2 2027 (May 2027) | 0 | -- | 0 | 0 | 10 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 5.53B | -- | 5.45B | 5.64B | 12 |
| FQ2 2028 (May 2028) | 5.44B | -- | 5.36B | 5.55B | 16 |
| FQ1 2028 (Feb 2028) | 5.36B | -- | 5.27B | 5.46B | 8 |
| FQ4 2027 (Nov 2027) | 5.27B | -- | 5.19B | 5.37B | 9 |
| FQ3 2027 (Aug 2027) | 7.11B | -- | 7.11B | 7.11B | 11 |
| FQ2 2027 (May 2027) | 4.95B | -- | 4.9B | 5.03B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 31.88 | 31.88 | 100% | |
| FQ3 2025 (Aug 2025) | 50.02 | 50.02 | 100% | |
| FQ2 2025 (May 2025) | 36.33 | 36.33 | 100% | |
| FQ1 2025 (Feb 2025) | 28.29 | 28.29 | 100% | |
| FQ4 2024 (Nov 2024) | 33.4 | 33.4 | 100% | |
| FQ3 2024 (Aug 2024) | 53.28 | 53.28 | 100% | |
| FQ2 2024 (Apr 2024) | 37.73 | 37.73 | 100% | |
| FQ2 2022 (May 2022) | 29.93 | 29.93 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $4.63B | $4628.63M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $6.24B | $6242.73M | 100% |
| FQ2 2025 (May 2025) | $0B | $4.46B | $4464.34M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $3.95B | $3952.01M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $4.28B | $4279.64M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $6.21B | $6205.38M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $4.24B | $4235.48M | 100% |
| FQ2 2022 (May 2022) | $0B | $3.87B | $3865.22M | 100% |